Supplement 1

1. Plotkin SR, Blakeley JO, Dombi E, et al. Achieving consensus for clinical trials: the REiNS International Collaboration. Neurology 2013 Nov 19;81(21 Suppl 1):S1-S5. [PDF]

2. Wolters PL, Martin S, Merker VL, et al. Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials. Neurology 2013 Nov 19;81(21 Suppl 1):S6-14. [PDF]

3. Fisher MJ, Avery RA, Allen JC, et al. Functional outcome measures for NF1-associated optic pathway glioma clinical trials. Neurology 2013 Nov 19;81:(21 Suppl 1)S15-S24. [PDF]

4. Plotkin SR, Ardern-Holmes SL, Barker FG, et al. Hearing and facial function outcomes for neurofibromatosis 2 clinical trials. Neurology 2013 Nov 19;81:(21 Suppl 1)S25-S32. [PDF]

5. Dombi E, Ardern-Holmes SL, Babovic-Vuksanovic D, et al. Recommendations for imaging tumor response in neurofibromatosis clinical trials. Neurology 2013 Nov 19;81(21 Suppl 1):S33-S40. [PDF]

6. Widemann BC, Blakeley JO, Dombi E, et al. Conclusions and future directions for the REiNS International Collaboration. Neurology 2013 Nov 19;81(21 Suppl 1):S41-4. [PDF]

Supplement 2

1. Widemann BC, Plotkin SR. Consensus for NF clinical trials: Recommendations of the REiNS collaboration (Supplement II).  Neurology 2016 Aug 16;87(7 Suppl 1);S1-S3. [PDF]

2. Wolters PL, Martin S, Merker VL, et al. Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials. Neurology 2016 Aug 16;87(7 Suppl 1):S4-S12. [PDF]

3. Plotkin SR, Davis SD, Robertson KA, et al. Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1. Neurology 2016 Aug 16;87(7 Suppl 1):S13-20. [PDF]

4. Walsh KS, Janusz J, Wolters PL, et al. Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention. Neurology 2016 Aug 16;87(7 Suppl 1): S21-30. [PDF]

5. Ahlawat S, Fayad LM, Khan MS, et al. Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis. Neurology 2016 Aug 16;87(7 Suppl 1): S31-9. [PDF]

6. Hanemann CO, Blakeley JO, Nunes FP, et al. Current status and recommendations for biomarkers and biobanking in neurofibromatosis. Neurology 2016 Aug 16;87(7 Suppl 1): S40-8. [PDF]